JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Schippling S, Kempf C, Büchele F, Jelcic I, Bozinov O, Bont A, Linnebank M, Sospedra M, Weller M, Budka H, et al. Ann Neurol. 2013 Jul 19. PMID: 23868420. Abstract CommentRecommendBookmarkWatch